Evidence map›Paper›PMID 38951718›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Cerebrovascular reactivity MRI as a biomarker for cerebral small vessel disease-related cognitive decline: Multi-site validation in the MarkVCID Consortium.

Peiying Liu, Zixuan Lin, Kaisha Hazel, George Pottanat, Cuimei Xu, Dengrong Jiang, Jay J Pillai, Emma Lucke, Christopher E Bauer, Brian T Gold and 20 more

Abstract readMulticenter StudyValidation Study
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Optimal markers of treatment response to vasodilatory drugs in small vessel disease: An OxHARP trial analysis.International journal of stroke : official journal of the International Stroke Society · 2026
    Trial
  2. Article
  3. Review
  4. Cognitive reserve against vascular contributions to cognitive impairment and dementia: A scoping review.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Plasma placental growth factor as a susceptibility biomarker for longitudinal cognitive change.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  14. Low frequency BOLD oscillations,medRxiv : the preprint server for health sciences · 2025
    Article
  15. Article
  16. Measuring cerebrovascular reactivity in a hemodialysis cohort.Cerebral circulation - cognition and behavior · 2025
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Peiying LiuDepartment of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Zixuan LinDepartment of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Kaisha HazelDepartment of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
George PottanatDepartment of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Cuimei XuDepartment of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Dengrong JiangDepartment of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jay J PillaiDepartment of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Emma LuckeDepartment of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Christopher E BauerDepartment of Neuroscience, University of Kentucky, Lexington, Kentucky, USA.
Brian T GoldDepartment of Neuroscience, University of Kentucky, Lexington, Kentucky, USA.
Steven M GreenbergDepartment of Neurology, Massachusetts General Hospital Stroke Research Center, Harvard Medical School, Boston, Massachusetts, USA.
Karl G HelmerDepartment of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Kay JannLaboratory of Functional MRI Technology, Keck School of Medicine, Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, California, USA.
Gregory JichaDepartment of Neurology, University of Kentucky, Lexington, Kentucky, USA.
Joel KramerDepartment of Neurology, University of California, San Francisco, San Francisco, California, USA.
Pauline MaillardDepartment of Neurology, University of California, Davis, Sacramento, California, USA.
Rachel M MulavelilGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, UT Health San Antonio, San Antonio, Texas, USA.
Pavel RodriguezGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, UT Health San Antonio, San Antonio, Texas, USA.
Claudia L SatizabalGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, UT Health San Antonio, San Antonio, Texas, USA.
Kristin SchwabDepartment of Neurology, Massachusetts General Hospital Stroke Research Center, Harvard Medical School, Boston, Massachusetts, USA.
Sudha SeshadriGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, UT Health San Antonio, San Antonio, Texas, USA.
Herpreet SinghDepartment of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Ángel G Velarde DediósGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, UT Health San Antonio, San Antonio, Texas, USA.
Danny J J WangLaboratory of Functional MRI Technology, Keck School of Medicine, Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, California, USA.
Rita R KalyaniDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abhay MoghekarDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Paul B RosenbergDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Sevil YasarDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Marilyn AlbertDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Hanzhang LuDepartment of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-3871-1564

Funding

Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI Corinne Pettigrew · 2020 to 2026
$29.3M
UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEE-WAY JIN · 2021 to 2026
$25.2M
University of Kentucky Alzheimer's Disease Research CenterP30AG072946 · NIA · UNIVERSITY OF KENTUCKY · PI LINDA J VAN ELDIK · 2021 to 2026
$23.5M
VCID Biomarkers Coordinating CenterU24NS100591 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Steven M Greenberg · 2016 to 2026
$19.8M
TRD 4: Platforms for multi-modal and multi-scale imaging dataP41EB031771 · NIBIB · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI Hanzhang Lu, Peter CM Van Zijl · 2021 to 2026
$9.9M
Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel DiseaseUH3NS100614 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KASHANI, AMIR H, RINGMAN, JOHN M · 2018 to 2020
$4.3M
Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkersU01NS100588 · NINDS · JOHNS HOPKINS UNIVERSITY · PI ALBERT, MARILYN S., LU, HANZHANG · 2023 to 2025
$4.1M
Development of MRI microvascular biomarkers in cognitive impairment and dementiaUH3NS100588 · NINDS · JOHNS HOPKINS UNIVERSITY · PI ALBERT, MARILYN S., LU, HANZHANG · 2018 to 2020
$3.5M
Small vessel disease biomarkers in a longitudinally-followed "stroke-belt" cohortUH3NS100606 · NINDS · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, WILCOCK, DONNA M · 2018 to 2020
$3.4M
Microglial, Inflammatory and Omics Markers of Cerebral Small Vessel Disease in the CHARGE ConsortiumUH3NS100605 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FORNAGE, MYRIAM, SESHADRI, SUDHA · 2018 to 2020
$3.0M
Gas-free cerebrovascular reactivity (CVR) MRI in vascular cognitive impairmentR01NS115771 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI LIU, PEIYING · 2021 to 2025
$3.0M
An integrated vascular MR imaging suite in brain diseasesR01NS106702 · NINDS · JOHNS HOPKINS UNIVERSITY · PI LU, HANZHANG · 2018 to 2022
$2.7M
NIA NIH HHS P30 AG066507NIA NIH HHS P30 AG072946NIA NIH HHS P30 AG072972NIA NIH HHS R01 AG064792NIA NIH HHS R01 AG071515NIA NIH HHS R01 AG085299NIBIB NIH HHS P41 EB031771NIH HHS P41 EB031771NIH HHS R01 NS115771NIH HHS U24 NS100591NIH HHS UH3 NS100588NIH HHS UH3 NS100605NIH HHS UH3 NS100606NIH HHS UH3 NS100614NINDS NIH HHS R01 NS106702NINDS NIH HHS R01 NS106711NINDS NIH HHS R01 NS115771NINDS NIH HHS U01 NS100588NINDS NIH HHS U24 NS100591NINDS NIH HHS UH3 NS100588NINDS NIH HHS UH3 NS100605NINDS NIH HHS UH3 NS100606NINDS NIH HHS UH3 NS100614
6 · The paper itself

Abstract

introductionVascular contributions to cognitive impairment and dementia (VCID) represent a major factor in cognitive decline in older adults. The present study examined the relationship between cerebrovascular reactivity (CVR) measured by magnetic resonance imaging (MRI) and cognitive function in a multi-site study, using a predefined hypothesis.

methodsWe conducted the study in a total of three analysis sites and 263 subjects. Each site performed an identical CVR MRI procedure using 5% carbon dioxide inhalation. A global cognitive measure of Montreal Cognitive Assessment (MoCA) and an executive function measure of item response theory (IRT) score were used as outcomes.

resultsCVR and MoCA were positively associated, and this relationship was reproduced at all analysis sites. CVR was found to be positively associated with executive function. DISCUSSION: The predefined hypothesis on the association between CVR and a global cognitive score was validated in three independent analysis sites, providing support for CVR as a biomarker in VCID. HIGHLIGHTS: This study measured a novel functional index of small arteries referred to as cerebrovascular reactivity (CVR). CVR was positively associated with global cognition in older adults. This finding was observed in three independent cohorts at three sites. Our statistical analysis plan was predefined before beginning data collection.

Indexed as

BiomarkersCerebral Small Vessel DiseasesCognitive DysfunctionMagnetic Resonance ImagingAgedCerebrovascular CirculationExecutive FunctionFemaleHumansMaleMental Status and Dementia TestsNeuropsychological TestsBiomarkersblood oxygenation level dependentcarbon dioxidecerebrovascular reactivitycognitive functionmagnetic resonance imagingMontreal Cognitive Assessmentvascular cognitive impairmentvascular cognitive impairment and dementia

Identifiers

PMID38951718
PMCPMC11350011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.